T. Feijtel, G. Boeije, M. Matthies, A. Young, G. Morris, C. Gandolfi, B. Hansen, K. K. Fox, M. S. Holt, V. Koch, R. Schroder, G. Cassani, D. Schowanek, J. Rosemblom and H. Niessen, Chemosphere, 1997, 34, 2351–2373.
Following the success of the first edition, this pioneering study of pharmaceuticals in the environment has been updated and greatly extended.
Nakada, N., Tanishima, T., Shinohara, H., Kiri, K. and Takada, H. (2006) Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research 40(17), ...
Aherne GW, Hardcastle A, Nield AH (1990) Cytotoxic drugs and the aquatic environment. Estimation of bleomycin in ... Science 301:1027 Greiner P, Ronnefahrt I (2002) Management of environmental risks in the life cycle of pharmaceuticals.
throughout their life-cycle, but they do need to be functionally persistent. In other words they have to be stable enough to remain unchanged during a realistic shelf-life and to be able to be transported, unchanged, though various ...
Following the success of the first edition, this pioneering study of pharmaceuticals in the environment has been updated and greatly extended.
Pharmaceuticals in the Environment
About 4000 medical compounds are being used in the drugs applied today.